secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC)
CIK:        0001500198
Form:       8-K
Filed at:   2024-06-21T23:59:59+00:00
Accession:  0001213900-24-054782
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 3.03, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuroOne amends bylaws: reduces stockholder quorum to one-third, updates proxy rules
--------------------------------------------------------------------------------

- Stockholder quorum reduced from majority to one-third of outstanding voting power.
- New universal proxy compliance requirement under SEC Rule 14a-19 for director nominations.
- Enhanced disclosure obligations for stockholder nominations and proposals, including derivative interests.
- Special meeting nominators must hold 10% of voting power and be stockholder at notice and record dates.
- Clarified personal jurisdiction and service of process for foreign actions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024054782/0001213900-24-054782-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1500198/000121390024054782/ea0208217-8k_neuro.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-054782

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer